{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:42:52Z","timestamp":1791200572991,"version":"4.2.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.pt.2007.08.004","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T11:19:13Z","timestamp":1189250353000},"page":"494-501","source":"Crossref","is-referenced-by-count":64,"title":["Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi"],"prefix":"10.1016","volume":"23","author":[{"given":"Jacques J.","family":"Kessl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Meshnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard L.","family":"Trumpower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2007.08.004_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2001.64.1","article-title":"The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden","volume":"64","author":"Breman","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2007.08.004_bib2","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1021\/ja01190a001","article-title":"Naphthoquinone antimalarials","volume":"70","author":"Fieser","year":"1948","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pt.2007.08.004_bib3","first-page":"112","article-title":"Naphthoquinone antimalarials. XX. Metabolic degradation","volume":"94","author":"Fieser","year":"1948","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pt.2007.08.004_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0169-4758(93)90040-M","article-title":"Atovaquone \u2013 a novel broad-spectrum anti-infective drug","volume":"9","author":"Hudson","year":"1993","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2007.08.004_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/AAC.34.2.225","article-title":"Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis","volume":"34","author":"Hughes","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2007.08.004_bib6","first-page":"220S","article-title":"Open-label efficacy and safety trial of 42 days of 566C80 for Pneumocystis carinii pneumonia in AIDS patients","volume":"38","author":"Dohn","year":"1991","journal-title":"J. Protozool."},{"key":"10.1016\/j.pt.2007.08.004_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0140-6736(92)92172-C","article-title":"Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program","volume":"340","author":"Kovacs","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2007.08.004_bib8","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2310\/7060.2003.35050","article-title":"The safety of atovaquone\/proguanil in long-term malaria prophylaxis of non-immune adults","volume":"10","author":"Petersen","year":"2003","journal-title":"J. Travel Med."},{"key":"10.1016\/j.pt.2007.08.004_bib9","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/jac\/36.6.1073","article-title":"Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria","volume":"36","author":"Chiodini","year":"1995","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2007.08.004_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/expr.1995.1049","article-title":"Interactions of atovaquone and other antimalarial drugs against Plasmodium falciparum in vitro","volume":"80","author":"Canfield","year":"1995","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2007.08.004_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2007.08.004_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/375599","article-title":"Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a non-immune traveler to East Africa","volume":"37","author":"Schwartz","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/00365540310016862","article-title":"Atovaquone\/proguanil resistance in Africa: a case report","volume":"35","author":"David","year":"2003","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/bmj.326.7390.628","article-title":"Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports","volume":"326","author":"Farnert","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.pt.2007.08.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-1-1","article-title":"Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria","volume":"1","author":"Fivelman","year":"2002","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2007.08.004_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2875-5-82","article-title":"Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa","volume":"5","author":"Happi","year":"2006","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2007.08.004_bib17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.trstmh.2006.02.004","article-title":"Prevalence of Plasmodium falciparum Cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance","volume":"100","author":"Berry","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2007.08.004_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2875-3-14","article-title":"Malarone treatment failure not associated with previously described mutations in the Cytochrome b gene","volume":"3","author":"Wichmann","year":"2004","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2007.08.004_bib19","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1086\/424469","article-title":"European Network on Surveillance of Imported Infectious Diseases. Screening for mutations related to atovaquone\/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe","volume":"190","author":"Wichmann","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/318835","article-title":"Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS","volume":"183","author":"Kazanjian","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib21","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1086\/339551","article-title":"Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome","volume":"34","author":"Chirgwin","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1054\/drup.2001.0221","article-title":"Are Cytochrome b gene mutations the only cause of atovaquone resistance in Pneumocystis?","volume":"4","author":"Kaneshiro","year":"2001","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.pt.2007.08.004_bib23","series-title":"Encyclopedia of Biochemistry","first-page":"528","article-title":"The cytochrome bc1 complex","author":"Trumpower","year":"2004"},{"key":"10.1016\/j.pt.2007.08.004_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pt.2007.08.004_bib25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1146\/annurev.biochem.69.1.1005","article-title":"Structure and function of cytochrome bc1 complexes","volume":"69","author":"Berry","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pt.2007.08.004_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0969-2126(00)00152-0","article-title":"Structure at 2.3 A resolution of the cytochrome bc1 complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment","volume":"8","author":"Hunte","year":"2000","journal-title":"Structure"},{"key":"10.1016\/j.pt.2007.08.004_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jmb.2004.05.065","article-title":"Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the Cytochrome bc1 complex","volume":"341","author":"Esser","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pt.2007.08.004_bib28","doi-asserted-by":"crossref","first-page":"31303","DOI":"10.1074\/jbc.M302195200","article-title":"Structure of the yeast cytochrome bc1 complex with a hydroxyquinone anion Qo site inhibitor bound","volume":"278","author":"Palsdottir","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2007.08.004_bib29","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1021\/bi026252p","article-title":"The crystal structure of mitochondrial Cytochrome bc1 in complex with famoxadone: the role of aromatic-aromatic interaction in inhibition","volume":"41","author":"Gao","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pt.2007.08.004_bib30","doi-asserted-by":"crossref","first-page":"31312","DOI":"10.1074\/jbc.M304042200","article-title":"Molecular basis for atovaquone binding to the cytochrome bc1 complex","volume":"278","author":"Kessl","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2007.08.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(00)00184-5","article-title":"Characterization of Cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance","volume":"108","author":"McFadden","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2007.08.004_bib32","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2007.08.004_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arcped.2004.10.013","article-title":"Malaria chemoprophylaxis in traveling children","volume":"12","author":"Minodier","year":"2005","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.pt.2007.08.004_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/426074","article-title":"Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection","volume":"40","author":"Hughes","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/432551","article-title":"A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy","volume":"192","author":"McGready","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00228-005-0969-7","article-title":"The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women","volume":"61","author":"Na-bangchang","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2007.08.004_bib37","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1086\/314509","article-title":"Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure","volume":"178","author":"Walker","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2958.1999.01515.x","article-title":"Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites","volume":"33","author":"Srivastava","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2007.08.004_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/expr.2001.4639","article-title":"Plasmodium falciparum: the effects of atovaquone resistance on respiration","volume":"98","author":"Suswam","year":"2001","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2007.08.004_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2875-2-5","article-title":"Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker","volume":"2","author":"Schwobel","year":"2003","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2007.08.004_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0890-8508(03)00006-9","article-title":"Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene","volume":"17","author":"Gil","year":"2003","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.pt.2007.08.004_bib42","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1086\/424469","article-title":"Screening for mutations related to atovaquone\/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe","volume":"190","author":"Wichmann","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2007.08.004_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/AAC.35.2.293","article-title":"Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii","volume":"35","author":"Araujo","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2007.08.004_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08820530500231961","article-title":"Toxoplasmosis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.pt.2007.08.004_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0166-6851(92)90046-M","article-title":"The 6-kb element of Plasmodium falciparum encodes mitochondrial cytochrome genes","volume":"52","author":"Feagin","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2007.08.004_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0968-0004(00)01674-1","article-title":"Mitochondria, oxygen free radicals, disease and aging","volume":"25","author":"Raha","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.pt.2007.08.004_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1055-7903(92)90020-H","article-title":"Evolutionary relationships within the fungi: analyses of nuclear small subunit rRNA sequences","volume":"1","author":"Bruns","year":"1992","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.pt.2007.08.004_bib48","first-page":"70S","article-title":"Pentamidine sensitivity and resistance in Saccharomyces cerevisiae as a model for pentamidine effects on Pneumocystis carinii","volume":"38","author":"Hatfield","year":"1991","journal-title":"J. Protozool."},{"key":"10.1016\/j.pt.2007.08.004_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0091-679X(01)65022-2","article-title":"Genetic transformation of Saccharomyces cerevisiae mitochondria","volume":"65","author":"Bonnefoy","year":"2001","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.pt.2007.08.004_bib50","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1128\/AAC.47.9.2725-2731.2003","article-title":"Recapitulation in Saccharomyces cerevisiae of cytochrome b mutations conferring resistance to atovaquone in Pneumocystis jirovecii","volume":"47","author":"Hill","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2007.08.004_bib51","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1074\/jbc.M309984200","article-title":"Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc1 complex of Saccharomyces cerevisiae","volume":"279","author":"Kessl","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2007.08.004_bib52","doi-asserted-by":"crossref","first-page":"17142","DOI":"10.1074\/jbc.M500388200","article-title":"Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae","volume":"280","author":"Kessl","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2007.08.004_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molbiopara.2005.12.002","article-title":"Molecular basis of Toxoplasma gondii atovaquone resistance modeled in Saccharomyces cerevisiae","volume":"146","author":"Kessl","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2007.08.004_bib54","doi-asserted-by":"crossref","first-page":"27458","DOI":"10.1074\/jbc.M502319200","article-title":"Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system","volume":"280","author":"Mather","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2007.08.004_bib55","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/jps.20681","article-title":"Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor","volume":"95","author":"Xiang","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.pt.2007.08.004_bib56","doi-asserted-by":"crossref","first-page":"36036","DOI":"10.1074\/jbc.M608026200","article-title":"Investigating the Qn site of the cytochrome bc1 complex in S. cerevisiae with mutants resistant to Ilicicolin H, a novel Qn site inhibitor","volume":"281","author":"Ding","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2007.08.004_bib57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ps.1066","article-title":"Re-examination of inhibitor resistance conferred by Qo-site mutations in cytochrome b using yeast as a model system","volume":"61","author":"Fisher","year":"2005","journal-title":"Pest Manag. Sci."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492207002176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492207002176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:10:53Z","timestamp":1556842253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492207002176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1471492207002176"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2007.08.004","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}